Department of Child and Adolescent Medicine, University Hospitals of Geneva, Geneva 1211, Switzerland.
Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):43-9. doi: 10.1007/s10096-012-1712-9. Epub 2012 Aug 18.
The acquisition of specific antibodies is paramount to protect children against pneumococcal diseases, and a better understanding of how age, ethnicity and/or Streptococcus pneumoniae (Spn) nasopharyngeal carriage influence the acquisition of antibodies to pneumococcal surface proteins (PSP) is important for the development of novel serodiagnostic and immunisation strategies. IgG antibody titres against three conserved PSP (PhtD, PcpA and PrtA) in the sera of 451 healthy children aged 1 to 24 months from Israel [Jewish (50.1 %) and Bedouin (49.9 %)] were measured by enzyme-linked immunosorbent assay (ELISA), while nasopharyngeal swabs from these children were assessed for the presence of Spn. Globally, anti-PhtD and anti-PrtA geometric mean concentrations (GMC; EU/ml) were high at <2.5 months of age [PhtD: 35.3, 95 % confidence interval (CI) 30.6-40.6; PrtA: 71.2, 95 % CI 60-84.5], was lower at 5-7 months of age (PhtD: 10, 95 % CI 8-12.4; PrtA: 17.9, 95 % CI 14.4-22.1) and only increased after 11 months of age. In contrast, an increase in anti-PcpA was observed at 5-7 months of age. Anti-PcpA and anti-PrtA, but not anti-PhtD, were significantly higher in Bedouin children (PcpA: 361.6 vs. 226.3, p = 0.02; PrtA: 67.2 vs. 29.5, p < 0.001) in whom Spn nasopharyngeal carriage was identified earlier (60 % vs. 38 % of carriers <6 months of age, p = 0.002). Spn carriage was associated with significantly higher anti-PSP concentrations in carriers than in non-carriers (p < 0.001 for each PSP). Thus, age, ethnicity and, essentially, nasopharyngeal carriage exert distinct cumulative influences on infant responses to PSP. These specific characteristics are worthwhile to include in the evaluation of pneumococcal seroresponses and the development of new PSP-based vaccines.
获得针对肺炎球菌疾病的特异性抗体对于保护儿童至关重要,更好地了解年龄、种族和/或肺炎链球菌(Spn)鼻咽携带如何影响针对肺炎球菌表面蛋白(PSP)的抗体获得,对于开发新型血清诊断和免疫策略非常重要。通过酶联免疫吸附试验(ELISA)测量了来自以色列的 451 名 1 至 24 个月大的健康儿童(犹太裔 50.1%,贝都因人 49.9%)血清中的三种保守 PSP(PhtD、PcpA 和 PrtA)的 IgG 抗体滴度,同时评估了这些儿童的鼻咽拭子中是否存在 Spn。在全球范围内,<2.5 个月龄时,抗 PhtD 和抗 PrtA 的几何平均浓度(GMC;EU/ml)较高[PhtD:35.3,95%置信区间(CI)30.6-40.6;PrtA:71.2,95%CI 60-84.5],5-7 个月龄时较低[PhtD:10,95%CI 8-12.4;PrtA:17.9,95%CI 14.4-22.1],仅在 11 个月龄后增加。相比之下,在 5-7 个月龄时观察到抗 PcpA 增加。与犹太裔儿童相比,贝都因人儿童的抗 PcpA 和抗 PrtA 更高(但抗 PhtD 则较低)(PcpA:361.6 对 226.3,p=0.02;PrtA:67.2 对 29.5,p<0.001),他们更早地发现了 Spn 鼻咽携带(60%对<6 个月龄的携带者,p=0.002)。Spn 携带与携带者的抗 PSP 浓度显著高于非携带者(每个 PSP 均为 p<0.001)相关。因此,年龄、种族以及实质上的鼻咽携带对婴儿对 PSP 的反应产生了独特的累积影响。这些特定特征值得在评估肺炎球菌血清反应和开发新的基于 PSP 的疫苗时进行考虑。